Pfizer reports strong half-year earnings growth, dividend payout

Pfizer Limited released its unaudited financial results for the quarter and half-year ended September 30, 2025, reporting a net profit of ₹380.77 crore for the half-year, a substantial increase from ₹309.06 crore in the prior year. Total income for the half-year also rose to ₹1,354.41 crore, up from ₹1,236.36 crore in the corresponding period of 2024. For the quarter, net profit was ₹189.02 crore, with total income at ₹684.19 crore.

Earnings per share (basic and diluted) for the half-year stood at ₹83.23, compared to ₹67.55 for the same period last year. The company's total assets as of September 30, 2025, were ₹4,605.52 crore.

The board of directors approved these results at a meeting held on November 12, 2025. The company also confirmed a final dividend of ₹35 per equity share and a special dividend of ₹130 per equity share for the financial year ended March 31, 2025, totaling ₹165 per equity share, paid on July 25, 2025.